Plain-English translation of NCT07458516 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term observation study designed to track how diabetic eye disease progresses in people with type 2 diabetes. Rather than testing a new medication, researchers will use advanced imaging techniques—including special eye scans called optical coherence tomography (OCT)—to carefully monitor changes in your eyes over time and better understand which patients are at highest risk of losing vision.
Many people with diabetic eye disease don't have symptoms until the condition becomes severe and vision loss occurs. By studying how the disease progresses using modern imaging, doctors hope to identify earlier warning signs so they can offer timely treatment to prevent serious complications.
You likely qualify if…
You likely don't qualify if…
You would attend visits where researchers use advanced imaging technology to take detailed pictures and scans of the back of your eye. These scans are painless and non-invasive—similar to having your eyes photographed. Over the study period, you would return for periodic visits so doctors can track any changes in your eyes and better understand how your condition is progressing.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
Portugal
Sponsor
Association for Innovation and Biomedical Research on Light and Image
Collaborators
Fundação para a Ciência e a Tecnologia
Enrollment target
~100 participants
Started
November 2025
Primary completion
December 2027
Age range
35 Years – 80 Years
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Joana Tavares, PhD
AIBILI - Associação para a Investigação Biomédica e Inovação em Luz e Imagem
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.